Table 3.
Chronic hepatitis | F0-F2 | F3-F4 | SR | NSR | Healthy controls | ||
n = 284 (%) | n = 202 (%) | n = 82 (%) | n =101 (%) | n =98 (%) | n = 193 (%) | ||
CCL2G | CCR2A | 31 (10.9) | 22 (10.9) | 9 (11.0) | 10 (9.9) | 11 (11.2) | 13 (6.7) |
CCL2G | CCR2G | 85 (29.9) | 57 (28.2) | 28 (34.1) | 27 (26.7) | 32 (32.6) | 61 (31.6) |
CCL2A | CCR2A | 48 (16.9) | 34 (16.8) | 14 (17.1) | 19 (18.8) | 13 (13.3) | 24 (12.4) |
CCL2A | CCR2G | 120 (42.2) | 89 (44.1) | 31 (37.8) | 45 (44.5) | 42 (42.8) | 95 (49.2) |
F0-F2 = no fibrosis-mild fibrosis, F3-F4 = severe fibrosis-cirrhosis. SR: sustained response; NSR: no sustained response.